Article Details

Lytix Biopharma announces positive phase I data for LTX-315

Retrieved on: 2021-05-10 07:07:30

Tags for this article:

Click the tags to see associated articles and topics

Lytix Biopharma announces positive phase I data for LTX-315. View article details on hiswai:

Excerpt

OSLO, Norway I May 10, 2021 I Lytix Biopharma AS, a Norwegian clinical-stage immunoncology therapeutic company developing oncolytic molecule ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up